Wordt geladen...
Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
The mechanisms by which SGLT‐2 inhibitors lower albuminuria are incompletely understood. We assessed in a post‐hoc analysis of a cross‐over trial the effects of the SGLT2 inhibitor dapagliflozin on glomerular markers (IgG to IgG4 and IgG to albumin), tubular markers (urinary KIM‐1, NGAL and LFABP) a...
Bewaard in:
| Gepubliceerd in: | Diabetes Obes Metab |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6055757/ https://ncbi.nlm.nih.gov/pubmed/29573529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13301 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|